Amended Securities Exchange Agreement by and between Accelerated Pharma, Inc. and Certain Holders of Convertible Notes (Attached as Schedule A hereto) Dated: January 17, 2019Securities Exchange Agreement • July 24th, 2019 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledJuly 24th, 2019 Company Industry JurisdictionThis SECURITIES EXCHANGE AGREEMENT dated as of January 17, 2019 (this “Exchange Agreement”) between Accelerated Pharma, Inc., a Delaware corporation with offices located at 15W155 81st Street, Burr Ridge, IL 60527 (the “Company”), on the one hand, and certain persons and entities who are holders of convertible notes (the Notes”) issued by the Company as set forth on Exhibit A hereto (collectively, the “Holders”), on the other hand. The Company and the Holders are sometimes referred to individually, as a “Party” and collectively, as the “Parties.”
Form of Securities Exchange Agreement by and between Accelerated Pharma, Inc. and Certain Holders of Convertible Notes (Attached as Schedule A hereto) Dated: January 17, 2019Securities Exchange Agreement • January 25th, 2019 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledJanuary 25th, 2019 Company Industry JurisdictionThis SECURITIES EXCHANGE AGREEMENT dated as of January 17, 2019 (this “Exchange Agreement”) between Accelerated Pharma, Inc., a Delaware corporation with offices located at 15W155 81st Street, Burr Ridge, IL 60527 (the “Company”), on the one hand, and certain persons and entities who are holders of convertible notes (the Notes”) issued by the Company as set forth on Exhibit A hereto (collectively, the “Holders”), on the other hand. The Company and the Holders are sometimes referred to individually, as a “Party” and collectively, as the “Parties.”